Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects [Phase 1]
This clinical trial update reports on a Phase 1 study evaluating safety, tolerability, pharmacodynamics, and pharmacokinetics of JTE-451 in …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy [Phase 4]
A Phase 4 clinical trial evaluating the Varicella Zoster Vaccine in patients with plaque psoriasis treated with biologic therapy has been te…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab [Phase 1]
Phase 1 bioequivalence study comparing a single 1.5 mL dose of brodalumab to a two-dose regimen (1.0 mL + 0.5 mL) in patients with psoriasis…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects [Phase 1]
A Phase 1 trial by Stiefel evaluating the skin irritation potential of GSK2894512 Cream in healthy subjects has completed, with psoriasis li…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers [Phase 1]
Phase 1 trial evaluating the relative bioavailability of new oral formulations of SRT2104 in healthy male volunteers, with psoriasis listed …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-05-26FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for betamethasone dipropionate from Sun Pharmaceutical Industries, Inc., authorizing an update to th…
-
FDA approval · 2017-05-24FDA Approved: BETAMETHASONE VALERATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s original generic application for Betamethasone valerate. This approval makes the generic …
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis [NA]
A clinical trial comparing climatotherapy with a topical corticosteroids plus salicylic acid regimen for psoriasis; the current status is un…
-
FDA approval · 2017-05-11FDA Approved: ACITRETIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approves a supplemental application for Acitretin from Amneal Pharmaceuticals of New York LLC (ANDA 202552).
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects. [Phase 1]
Phase 1 study evaluating pharmacokinetics, safety, tolerability, immunogenicity, and pharmacodynamics of GSK2800528 in healthy subjects; stu…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and Soles [Phase 4]
Phase 4 clinical trial evaluating addition of excimer laser to acitretin tablets for psoriasis of the palms and soles; study terminated with…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis [Phase 3]
Phase 3 trial update assessing the efficacy and safety of Topoxy 0.25% Desoximetasone Cream for scalp psoriasis.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP) [Phase 2]
Phase 2 clinical trial DINUP investigating a DPP-4 inhibitor plus narrow-band UV-B light for psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis [Phase 2]
A Phase 2 trial of Neuroskin Forte for dry skin relief in psoriasis and atopic dermatitis (eczema) was terminated, with results posted in 20…
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population [Phase 3]
Phase 3 trial evaluating secukinumab for psoriasis in adult Turkish patients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects [Phase 1]
Phase 1 study assessing drug-drug interactions and intensive pharmacokinetic/pharmacodynamic profiling of brodalumab in psoriasis patients; …
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Safety and Efficacy of Etanercept in Patients With Psoriasis [NA]
This clinical trial update reports safety and efficacy findings for etanercept in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis [Phase 2]
Phase 2 trial updates the efficacy of alitretinoin for pustular psoriasis; results have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis
This clinical trial completed and reported results assessing psoriasis severity in Brazilian participants with chronic plaque-type psoriasis…
-
CLINICAL_TRIALS research · 2017-03-24Clinical Trial Update: Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life
A completed study focused on developing and validating a measure of the impact of psoriasis on chronic quality of life.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test [Phase 1]
A Phase 1 study from Bayer comparing BAY1003803 formulations in an open psoriasis plaque test has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
A terminated clinical trial at Massachusetts General Hospital studying monitoring and modification of atherosclerosis in patients with psori…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis [Phase 3]
Phase 3 trial comparing DFD01 spray to vehicle spray in moderate psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis [Phase 2]
Pfizer conducted a Phase 2 study of AN2728 topical ointment (tapinarof) for mild-to-moderate plaque psoriasis. The trial results were posted…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis [Phase 2]
Pfizer completed a Phase 2 safety and efficacy study of a novel topical ointment for plaque psoriasis. Results have been posted after the tr…